TikTok Influencers Driving Parallel Trade for Unlicensed Slimming Drug

An underground economy for unapproved slimming medications is being driven by social media fitness personalities and sellers on communication apps, according to recent findings.

Investigational Drug Acquiring Traction Online

Retatrutide, which is still in research studies, is being advertised by social media influencers for its supposed weight-reducing effects. Followers are encouraged to message these accounts privately for source information, while also obtaining discount codes.

Thriving Commerce on Social Networks

Additionally, a robust trade exists on messaging services, where communities with thousands of members share comparison images, injection guides and assertions of rapid UK delivery. Vendors market the drug there before redirecting buyers to other platforms for purchases.

Understanding Retatrutide

This medication is an experimental injectable developed by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help individuals reduce up to a quarter of their total weight. Referred to as the “triple G”, the substance is being hailed online as the next Ozempic.

Healthcare Professionals Express Concerns

Nevertheless, doctors and chemists have warned that the sale of what remains an unapproved medication in the UK is a cause for concern and could lead to users injecting substances of unknown origin.

Some experts said the demand for retatrutide could be linked to the increasing price of approved weight loss treatments such as Mounjaro.

Legal Position and Implementation

Selling the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unlicensed medication that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Some influencers attempt to sidestep the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still breach pharmaceutical, advertising, and customer regulations, potentially leading to penalties, prosecution or imprisonment.

Platform Reaction and Material Elimination

According to the social media company, the platform has taken down problematic material and banned related keywords and search suggestions. The company said it was dedicated to keeping the service secure and investing in strengthening compliance measures.

Online Trading Activities

Research also discovered communities with up to nine thousand members selling the experimental drug using Telegram's integrated discovery tool, which operates like a public directory. Entering “retatrutide” immediately brings up channels with thousands of users, filled with photos of weight loss, glowing testimonials and step-by-step instructions for mixing or injecting at home.

After moments of joining one group, a seller posted contact information, where the majority of transactions take place. The vendor sent an instruction manual and guaranteed delivery within two days. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. Not one asked about weight, health issues or past usage.

Item Details and Costs

Within these groups, posts display dark colored parcels with Royal Mail labels, claiming to contain new batches. One message read: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, mixed at residence with sterile water, or pre-filled pens typically sold at £160 for 20mg. When asked how long a injector should be used, sellers give contradictory responses ranging from a few weeks to “depends on your body”.

Service Moderation and Security Measures

A spokesperson for the messaging service stated it actively moderated dangerous material on its service including content that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are injecting substances they cannot confirm. Even if the research behind retatrutide is valid, these online products may not include what they advertise,” said Jason Murphy, the director of pharmacy at a pharmacy service.

A medical professional of Asda Online Doctor connected the surge in demand to current cost increases for authorized slimming drugs such as Mounjaro. “With prices rising, individuals are turning to online platforms. But fake treatments are extremely risky. You cannot know what’s contained or whether the conditions they were produced in was sterile,” she explained.

Her team has previously seen patients injured by self-injection from unverified suppliers. “We understand the disappointment, but purchasing from Telegram or WhatsApp is gambling with your well-being,” said Wyllie. “These substances could be contaminated or incorrectly dosed.”

Manufacturer Position

A representative from Eli Lilly said the substance was in third stage research studies and had not been reviewed or approved by any government authority anywhere in the world. “Therefore at this time no one can sell [it] for human use,” they explained, noting that any item “falsely representing itself as a Lilly investigational product not yet approved … may expose patients to possibly serious medical dangers”.